Literature DB >> 33629859

Aptamer Conjugated Gold Nanostar-Based Distance-Dependent Nanoparticle Surface Energy Transfer Spectroscopy for Ultrasensitive Detection and Inactivation of Corona Virus.

Avijit Pramanik1, Ye Gao1, Shamily Patibandla1, Dipanwita Mitra2, Martin G McCandless2, Lauren A Fassero2, Kalein Gates1, Ritesh Tandon2, Paresh Chandra Ray1.   

Abstract

The ongoing outbreak of the coronavirus infection has killed more than 2 million people. Herein, we demonstrate that Rhodamine 6G (Rh-6G) dye conjugated DNA aptamer-attached gold nanostar (GNS)-based distance-dependent nanoparticle surface energy transfer (NSET) spectroscopy has the capability of rapid diagnosis of specific SARS-CoV-2 spike recombinant antigen or SARS-CoV-2 spike protein pseudotyped baculovirus within 10 min. Because Rh-6G-attached single-stand DNA aptamer wrapped the GNS, 99% dye fluorescence was quenched because of the NSET process. In the presence of spike antigen or virus, the fluorescence signal persists because of the aptamer-spike protein binding. Specifically, the limit of detection for the NSET assay has been determined to be 130 fg/mL for antigen and 8 particles/mL for virus. Finally, we have demonstrated that DNA aptamer-attached GNSs can stop virus infection by blocking the angiotensin-converting enzyme 2 (ACE2) receptor binding capability and destroying the lipid membrane of the virus.

Entities:  

Year:  2021        PMID: 33629859      PMCID: PMC7927280          DOI: 10.1021/acs.jpclett.0c03570

Source DB:  PubMed          Journal:  J Phys Chem Lett        ISSN: 1948-7185            Impact factor:   6.475


The respiratory syndrome coronavirus-2 (SARS-CoV-2) epidemic has spread worldwide very rapidly, and it threatens the world economy, health, and social life.[1−10] As per the world health organization (WHO), more than 106 million people around the world have suffered the effects of the coronavirus disease of 2019 (COVID-19), and around 2.3 million have died worldwide.[1−5] For any disease, the immediate requirement is a fast and effective diagnostic of the virus, which is the key to prevent infection in the society.[5−15] In the current Letter, we report that spike protein-specific aptamer-attached gold nanostars (GNSs) can be used for rapid diagnosis of specific SARS-CoV-2 spike recombinant antigen or virus itself via a distance-dependent nanoparticle surface energy transfer (NSET) process.[16−22] Because gold nanoparticles exhibit 9–10 orders of magnitude higher quenching efficiency than typical small molecule dye–quencher pairs,[16−24] NSET spectroscopy using GNSs has the capability to be used as a biophysical tools beyond Förster resonance energy transfer (FRET).[16−22] It is now well-documented that because gold nanostars exhibit very high extinction coefficient, single GNS-based optical nanoprobes are comparable with an optical organic probe made with more than 106 dye molecules together.[16−27] Recent published data indicate that the receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein (S protein) is responsible for virus entry and disease pathogenesis.[3−15] Therefore, we have used spike protein-specific aptamer-attached GNSs for specific diagnosis and effective inhibition of the virus. As shown in Figure A, in the absence of spike protein, Rh-6G attached to single stand (ss) DNA aptamer-wrapped gold nanoparticle. Because of the above fact, the fluorescence signal from the Rh-6G dye is quenched by GNS via the NSET process. In contrast, as shown in Figure B,C, when SARS-CoV-2 antigen or virus particles are added, because of the aptamer–spike protein binding, the distance between the GNS and dye increases, and as a result, the fluorescence signal persists. We have used the observed NSET signal change in the absence or presence of antigen or virus for the detection purpose. Reported data show that spike protein-specific aptamer-attached GNS-based NSET can be used for the diagnosis of COVID-19 spike antigen at 130 fg/mL concentration level and virus at 8 particles/mL level.
Figure 1

(A) Schematic representation of the design criteria for Rh-6G conjugated DNA aptamer-attached gold nanostar (GNS)-based NSET. Because of the wrapping of ss-DNA on GNS, the NSET occurs between GNA and Rh-6G. (B) Scheme showing that spike protein-specific ss DNA aptamer binds with COVID-19 antigen, which allows DNA to be unwrapped from GNS. (C) Scheme showing that spike protein-specific DNA binds with SARS-CoV-2 spike protein pseudotyped baculovirus, which allows ss DNA to be unwrapped from GNS.

(A) Schematic representation of the design criteria for Rh-6G conjugated DNA aptamer-attached gold nanostar (GNS)-based NSET. Because of the wrapping of ss-DNA on GNS, the NSET occurs between GNA and Rh-6G. (B) Scheme showing that spike protein-specific ss DNA aptamer binds with COVID-19 antigen, which allows DNA to be unwrapped from GNS. (C) Scheme showing that spike protein-specific DNA binds with SARS-CoV-2 spike protein pseudotyped baculovirus, which allows ss DNA to be unwrapped from GNS. For the detection and inactivation, SARS-CoV-2 spike protein pseudotyped baculovirus has been used.[27,28] Because the S protein of the virus and host angiotensin-converting enzyme 2 (ACE2) binding is the key for infection spread, we have used aptamer-attached GNSs as an inhibitor for blocking virus spread.[8−15,27−30] In the current Letter, we demonstrate that the spike protein-specific DNA aptamer-attached GNSs (without Rh-6G) can be used to block the viral entry into cells. For this purpose, we have used ACE2 expressing HEK293T cell line.[27,28] Reported scanning and transmission electron microscopy and fluorescence microscopy data show that spike protein-specific DNA aptamer-attached GNSs can be used to stop the spread of the virus. For the design of Rh-6G conjugated ss-DNA aptamer-attached GNS, which is specific for binding with spike protein, we have used 5′-ATCCAGAGTGACGCAGCATTTCATCGGGTCCAAAAGGGGCTGCTCGGGATTGCGGATATGGACACGT-3′, DNA aptamer which has been reported recently to be specific for the SARS-CoV-2 spike glycoprotein.[12] As shown in the Figure A, ss-DNA (HS–(CH2)6–3′-oligo-5′-Rh-6G) was attached to GNS via thiol-gold chemistry, as we and others have reported before.[16−22] For this purpose, initially we have synthesized GNS using silver assisted seedless growth method in the presence of HEPES buffer.[23−25] We report the synthesis details in the Supporting Information. After that, GNSs were characterized by UV–vis spectroscopy and TEM as reported in Figure S1A,B in the Supporting Information. TEM data show that for GNS particles the spherical core diameter is around 15 ± 3 and branch length is around 12 ± 4 nm. The extinction spectra show that freshly prepared GNSs exhibit strong plasmon band with λmax ≈ 560 nm.[23] In the next step, ssDNA (HS–(CH2)6–Oligo-Rh-6G) aptamer was attached to GNS via thiol-gold chemistry. We have reported the synthesis details in the Supporting Information. Next, to determine how many aptamers are bound to GNS, we have separated aptamer from GNS by dissolving nanostar in 10 μM potassium cyanide. In the next step, from fluorescence recovery intensity measurement, we have found out that around 60–80 aptamers are attached to each GNS. As reported in Figure S1C in the Supporting Information and Figure A, the fluorescence signal from the Rh-6G-attached aptamer is totally quenched when it has been attached to a GNS. As shown in Figure A, when a Rh-6G conjugated ss DNA aptamer is attached to GNS surface via -SH linkage, the 5′-Rh-6G ends of ss DNA loop back onto the GNS surface.[16−22] In this condition, strong NSET[16−22] occurs between dye donor and GNS acceptor, which provided 99% of quenching efficiency, as reported in Figure A. As we and others have reported before, when Rh-6G is placed at a short distance on GNSs, which possesses a strong plasmon field, the electrons of Rh-6G participating in the excitation/emission process will interact with the field.[16−22] As a result, we have observed strong NSET, and it is because each GNS has the capability to be used as an excellent quencher, which is equivalent to several million dye molecules.[16−22] To understand whether in the Rh-6G conjugated ss (single strand) DNA aptamer GNS surface, 5′-Rh-6G ends of ss DNA can loop back onto GNS, we have added complementary DNA which will form a double helix structure.
Figure 2

(A) Fluorescence spectra from Rh-6G conjugated spike protein-specific DNA aptamer-attached GNS in the absence of antigen and presence of SARS-CoV-2 spike recombinant antigen (10 pg/mL), flu virus antigen (100 pg/mL), and rotavirus antigen (100 pg/mL). The ratio of DNA aptamer and COVID-19 antigen was kept as 1:1. (B) Plot showing how SERS intensity from Rh-6G conjugated DNA aptamer-attached GNS varies with the addition of antigen. The ratio of DNA aptamer and COVID-19 antigen was kept as 1:1. (C) Fluorescence spectra from Rh-6G conjugated spike protein-specific DNA aptamer-attached GNS in the presence of SARS-CoV-2 spike recombinant antigen (10 pg/mL), flu virus antigen (100 pg/mL), and rotavirus antigen (100 pg/mL). (C) Plot indicating the variation of log of (NSET intensity change due to the addition of spike recombinant antigen) with the log of (amount of spike recombinant antigen).

(A) Fluorescence spectra from Rh-6G conjugated spike protein-specific DNA aptamer-attached GNS in the absence of antigen and presence of SARS-CoV-2 spike recombinant antigen (10 pg/mL), flu virus antigen (100 pg/mL), and rotavirus antigen (100 pg/mL). The ratio of DNA aptamer and COVID-19 antigen was kept as 1:1. (B) Plot showing how SERS intensity from Rh-6G conjugated DNA aptamer-attached GNS varies with the addition of antigen. The ratio of DNA aptamer and COVID-19 antigen was kept as 1:1. (C) Fluorescence spectra from Rh-6G conjugated spike protein-specific DNA aptamer-attached GNS in the presence of SARS-CoV-2 spike recombinant antigen (10 pg/mL), flu virus antigen (100 pg/mL), and rotavirus antigen (100 pg/mL). (C) Plot indicating the variation of log of (NSET intensity change due to the addition of spike recombinant antigen) with the log of (amount of spike recombinant antigen). Because -ds (double stand) DNA is not conformationally flexible for bending, 5′-Rh-6G ends of -ds DNA cannot loop back onto GNSs. Because of this fact, the distance between GNS and Rh-6G dye increases. As a result, we have observed high fluorescence after the formation of -ds DNA, as reported in Figure S1E in the Supporting Information. The above experimental data is clear evidence that in ss DNA aptamer, the rhodamine 6G at the 3′ end can loop back onto the GNS surface. To understand better whether 5′-Rh-6G ends of ss DNA aptamers are adsorbed onto the GNS surface, a surface enhanced Raman intensity (SERS) enhancement experiment has been explored.[23−25] As reported in Figure B, excellent SERS intensity enhancement has been observed. The observed Raman mode from Rh-6G-attached ss DNA aptamers is N–C–C bending mode of the ethylamine group at 376 cm–1, as we and others reported before.[23−25] Similarly, we have also observed Raman modes due to the bending of the C–C–C ring at 615 cm–1 and C–H out-of-plane at 778 cm–1, as we and others reported before.[23−25] From the observed Raman modes, we have estimated that the Raman enhancement factor is ∼3.68 × 107, which clearly indicates that the 5′-Rh-6G ends of ss DNA aptamers are adsorbed onto the GNS surface. As shown in Figure B, because of the antigen–aptamer binding, the distance between GNS and Rh-6G dye increases when coronavirus antigens are added to spike protein-specific ss DNA conjugated GNS. As a result, fluorescence signal persists as reported in Figure S1D in the Supporting Information and in Figure C. The observed NSET intensity change in the presence of specific antigen has been used for detection purposes. It is now well-documented that aptamers are capable of binding with antigen protein via noncovalent interaction, such as hydrogen bonding, van der Waals forces, and other interactions.[11,12] Recently reported molecular dynamics simulations with experimental observation study indicate that our aptamers bind to several amino acid residues of the receptor-binding domain of the SARS-CoV-2 S protein.[12] A reported simulation study indicates that the cytosine base at 53 position, guanine base at 54 position, and adenine base at 66 position of the aptamer form a network of hydrogen bonds with glutamine, lysine, and tyrosine amino acids from receptor-binding domain of the SARS-CoV-2 S protein.[12] Similarly, the thymine base at 41 position of the aptamer forms a network of hydrogen bonds with threonine from the receptor-binding domain of the SARS-CoV-2 S protein.[12] Because of these antigen–aptamer interactions, the aptamer became straight and the distance between the GNS and the Rh-6G dye increased. To understand better whether 5′-Rh-6G ends of DNA aptamers are far from the GNS surface when specific antigen has been added, we also performed a SERS experiment.[23−25] As reported in Figure B, in the presence of spike antigen, we have not observed any Raman signal from Rh-6G conjugated ss DNA aptamer-attached GNSs. The observed SERS data clearly indicate that Rh-6G in ss DNA aptamer is not adsorbed onto the GNS surface after aptamer binds with spike antigen and that the distance between Rh-6G and GNS is several nanometers. As a result, we have not observed any SERS signal. In last few months, the FDA has authorized antigen tests for COVID-19 infection.[2] Our experimental data demonstrated that distance-dependent NSET can be used to detect the same virus antigens within 10 min of experimental time. For finding the limit of detection (LOD) of the reported distance-dependent NSET assay, we have determined the NSET intensity change in the presence of different amounts of spike antigen. As shown in Figure C, the distance-dependent NSET assay can recognize COVID-19-specific antigen even at the concentration of 100 fg/mL. As reported in Figure D, the log of NSET intensity difference (intensity after and before COVID-19 spike antigen) varies linearly with the log of the concentration of COVID-19 spike antigen. We used eq for finding the LOD for the distance-dependent NSET assay.[16−25] In our experiment the standard deviation of the blank (σ) has been measured in the absence of antigen. The slope of the calibration curve (S) has been calculated from the linear curve reported in Figure D. The LOD for the distance-dependent NSET assay has been determined to be ∼130 fg/mL for spike antigen. Selectivity of the 5′-Rh-6G conjugated DNA-attached GNS-based distance-dependent NSET assay has been demonstrated using flu virus antigen and rotavirus antigen separately. As shown in Figure A, we have not observed any distance-dependent NSET intensity variation for flu or rotavirus antigen, although we have used 100 pg/mL antigen. On the other hand, excellent distance-dependent NSET intensity variation can be noted when only 10 pg/mL spike antigen has been added. The above experimental data clearly indicate that the NSET assay can be used for specific recognition of SARS-CoV-2 spike recombinant antigen. As shown in Figure C, spike protein-specific DNA conjugated GNS-based NSET diagnosis of virus is based on the binding affinity of virus spike protein and aptamer. As reported in Figures B–D and S2C in the Supporting Information, because of the above interaction, the distance-dependent NSET intensity enhances abruptly. The reported distance-dependent NSET intensity variation has been used for the detection of the virus. Because the size of the virus (120–160 nm) is much greater than that of the GNS, electron microscopy images reported in Figures B and S2A,B in the Supporting Information show that several aptamer-attached GNSs are bound on the virus. To understand better whether 5′-Rh-6G ends of ss DNA aptamers are far from the GNS surface in the presence of virus, we have measured Raman signal with or without virus addition. As reported in Figure S2D in the Supporting Information, no Raman signal has been observed from Rh-6G conjugated ss DNA aptamer-attached GNS when viruses are present. The observed SERS data clearly indicate that Rh-6G in ss DNA aptamers are not adsorbed on the GNS surface after aptamer binds with the virus.
Figure 3

(A) SEM image of pseudo baculovirus-attached GNS. (B) How the fluorescence spectra from Rh-6G conjugated DNA aptamer-attached GNS varies when different amounts of virus are added. (C) Plot shows how the log of (fluorescence intensity difference in the presence and absence of baculovirus) varies with the log of (concentration of baculovirus). (D) Fluorescence image of pseudo baculovirus when they are attached with Rh-6G conjugated DNA aptamer bound GNS.

(A) SEM image of pseudo baculovirus-attached GNS. (B) How the fluorescence spectra from Rh-6G conjugated DNA aptamer-attached GNS varies when different amounts of virus are added. (C) Plot shows how the log of (fluorescence intensity difference in the presence and absence of baculovirus) varies with the log of (concentration of baculovirus). (D) Fluorescence image of pseudo baculovirus when they are attached with Rh-6G conjugated DNA aptamer bound GNS. Our experimental data indicate that distance-dependent NSET-based virus diagnosis can be performed within 10 min using the spike. To understand whether 5′-Rh-6G conjugated DNA-attached GNSs are bound onto the virus surface, we have also performed a fluorescence imaging experiment. As reported in Figure D, we can clearly see the red color image from the virus-attached nanosystem, which indicates that Rh-6G conjugated ss DNA-attached GNS bound virus and Rh-6G are far from the GNS surface. Sensitivity of the distance-dependent NSET assay for specific virus detection has been determined by varying the virus amount from 10 to 500 virus/mL. As shown in Figure B, distance-dependent NSET assay has the capability to identify coronavirus even at the 10 virus/mL concentration level. As reported in Figure C, the log of NSET intensity difference (intensity before and after virus addition) varies linearly with the log of the concentration of the virus. Using the linear curve reported in Figure F and eq , the LOD for distance-dependent NSET assay has been determined to be ∼8 virus/mL. To understand whether the Rh-6G conjugated spike protein-specific DNA aptamer-attached GNS-based NSET assay can be used for the detection of COVID-19-specific antigen or virus, we have performed an experiment using antigen or virus-infected artificial nasal mucus fluid samples. Artificial nasal mucus fluid was purchased from Biochemazone, Canada, and the nasal matrix was infected by adding different concentrations of COVID-19-specific antigen or virus, separately. As shown in Figure A, we have not observed NSET intensity change in the presence of only nasal matrix or nasal matrix infected with flu virus antigen. On the other hand, as reported in Figure B, the Rh-6G conjugated spike protein-specific DNA aptamer-attached GNS-based NSET assay has the capability to detect COVID-19-specific antigen even in the concentration of 100 fg/mL. Similarly, as reported in Figure C, the Rh-6G conjugated spike protein-specific DNA aptamer-attached GNS-based NSET assay has the capability to detect virus even in the concentration of 20 virus/mL.
Figure 4

(A) Fluorescence spectra from Rh-6G conjugated spike protein-specific DNA aptamer-attached GNS in the presence of only buffer, only artificial nasal matrix, and artificial nasal matrix infected with flu virus antigen (100 fg/mL). (B) Fluorescence spectra from Rh-6G conjugated spike protein-specific DNA aptamer-attached GNS in the presence of artificial nasal matrix infected with SARS-CoV-2 spike recombinant antigen (100 fg/mL and 300 fg/mL). (C) Fluorescence spectra from Rh-6G conjugated spike protein-specific DNA aptamer-attached GNS in the presence of artificial nasal matrix infected with pseudo baculovirus (20 virus particle/mL and 100 virus particle/mL)

(A) Fluorescence spectra from Rh-6G conjugated spike protein-specific DNA aptamer-attached GNS in the presence of only buffer, only artificial nasal matrix, and artificial nasal matrix infected with flu virus antigen (100 fg/mL). (B) Fluorescence spectra from Rh-6G conjugated spike protein-specific DNA aptamer-attached GNS in the presence of artificial nasal matrix infected with SARS-CoV-2 spike recombinant antigen (100 fg/mL and 300 fg/mL). (C) Fluorescence spectra from Rh-6G conjugated spike protein-specific DNA aptamer-attached GNS in the presence of artificial nasal matrix infected with pseudo baculovirus (20 virus particle/mL and 100 virus particle/mL) Next, we have determined whether spike protein-specific ss DNA aptamer-attached GNS can be used to inhibit viral replication. For this purpose, ACE2 expressing HEK293T cell line has been used.[27,28] In this experiment, we have used spike protein-specific ss DNA aptamer-attached GNS without Rh-6G. We have discussed experimental details in the Supporting Information. Reported virus inactivation data in Figure A–C and S3 in the Supporting Information indicate that ss DNA aptamer-attached GNS can block viral replication. 100% inhibition efficiency was observed for ss DNA aptamer-attached GNSs at the concentration of 100 ng/mL. On the other hand, less than 1% inhibition efficiency was achieved for only GNSs or aptamer at the same concentration level. The observed excellent inhibition efficiency for aptamer-attached GNSs can be because of the binding of the aptamer-attached GNSs to virus, resulting in the inability of the virus to bind with ACE2.[27−30] Experimental data shown in Figure B indicate that aptamer-attached GNS can destroy the lipid membrane of pseudo baculovirus, so that the virus particle collapses,[27−30] and as a result, it stops spreading.
Figure 5

(A) Fluorescence image showing strong green fluorescent protein expression from target cells when spike protein-specific ss DNA aptamer-attached GNS is absent. (B) SEM image indicates damage of virus lipid membrane of pseudo baculovirus, when virus and bioconjugated nanoparticles are incubated for an hour. Inserted TEM image also indicates the same. (C) Inhibition efficiency variation when only buffer (Mock), only GNS, 100 ng/mL spike protein-specific ss DNA aptamer only, and 100 ng/mL spike protein-specific ss DNA aptamer-attached GNS have been used. For this experiment, each of them were separately incubated with virus for an hour.

(A) Fluorescence image showing strong green fluorescent protein expression from target cells when spike protein-specific ss DNA aptamer-attached GNS is absent. (B) SEM image indicates damage of virus lipid membrane of pseudo baculovirus, when virus and bioconjugated nanoparticles are incubated for an hour. Inserted TEM image also indicates the same. (C) Inhibition efficiency variation when only buffer (Mock), only GNS, 100 ng/mL spike protein-specific ss DNA aptamer only, and 100 ng/mL spike protein-specific ss DNA aptamer-attached GNS have been used. For this experiment, each of them were separately incubated with virus for an hour. In conclusion, in this work we report that spike protein-specific aptamer-attached GNSs can be used for detection and inactivation of corona virus. Our finding indicates that rhodamine 6G (Rh-6G) dye conjugated DNA aptamer-attached GNS-based distance-dependent NSET has the capability to detect spike antigen or virus itself very rapidly, and results can be obtained in less than 10 min. Furthermore, the NSET assay is highly sensitive where LOD as low as 130 fg/mL can be achieved for SARS-CoV-2 spike recombinant antigen, and in the case of virus, the LOD is only 8 particles/mL. Finally, we demonstrate that 100% virus inhibition efficiency for aptamer-attached GNSs occurs via blocking the cell attachment process and damage of the lipid membrane. Although reported experimental data indicate that the aptamer conjugated GNSs have the capability for diagnosis and inhibition of corona virus, we are in the infancy of this research. In the next phase, we plan to move beyond the phase of demonstrations in the laboratory and find a way to move toward clinical applications.
  25 in total

1.  Inhibition of cytomegalovirus infection and photothermolysis of infected cells using bioconjugated gold nanoparticles.

Authors:  Bernadette M DeRussy; Madeline A Aylward; Zhen Fan; Paresh C Ray; Ritesh Tandon
Journal:  Sci Rep       Date:  2014-07-03       Impact factor: 4.379

2.  Nanoarchitecture Based SERS for Biomolecular Fingerprinting and Label-Free Disease Markers Diagnosis.

Authors:  Sudarson Sekhar Sinha; Stacy Jones; Avijit Pramanik; Paresh Chandra Ray
Journal:  Acc Chem Res       Date:  2016-12-08       Impact factor: 22.384

3.  Discovery of Aptamers Targeting the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein.

Authors:  Yanling Song; Jia Song; Xinyu Wei; Mengjiao Huang; Miao Sun; Lin Zhu; Bingqian Lin; Haicong Shen; Zhi Zhu; Chaoyong Yang
Journal:  Anal Chem       Date:  2020-07-02       Impact factor: 6.986

4.  Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles.

Authors:  Parikshit Moitra; Maha Alafeef; Ketan Dighe; Matthew B Frieman; Dipanjan Pan
Journal:  ACS Nano       Date:  2020-05-28       Impact factor: 15.881

5.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.

Authors:  Daniel Wrapp; Nianshuang Wang; Kizzmekia S Corbett; Jory A Goldsmith; Ching-Lin Hsieh; Olubukola Abiona; Barney S Graham; Jason S McLellan
Journal:  Science       Date:  2020-02-19       Impact factor: 47.728

6.  Assay Techniques and Test Development for COVID-19 Diagnosis.

Authors:  Linda J Carter; Linda V Garner; Jeffrey W Smoot; Yingzhu Li; Qiongqiong Zhou; Catherine J Saveson; Janet M Sasso; Anne C Gregg; Divya J Soares; Tiffany R Beskid; Susan R Jervey; Cynthia Liu
Journal:  ACS Cent Sci       Date:  2020-04-30       Impact factor: 14.553

7.  A novel coronavirus outbreak of global health concern.

Authors:  Chen Wang; Peter W Horby; Frederick G Hayden; George F Gao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

8.  Theoretical Design of Functionalized Gold Nanoparticles as Antiviral Agents against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Authors:  Aliyeh Mehranfar; Mohammad Izadyar
Journal:  J Phys Chem Lett       Date:  2020-11-23       Impact factor: 6.475

9.  Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.

Authors:  Linlin Zhang; Daizong Lin; Xinyuanyuan Sun; Ute Curth; Christian Drosten; Lucie Sauerhering; Stephan Becker; Katharina Rox; Rolf Hilgenfeld
Journal:  Science       Date:  2020-03-20       Impact factor: 47.728

View more
  14 in total

Review 1.  Aptamer-based biosensors for virus protein detection.

Authors:  Beibei Lou; Yanfei Liu; Meilin Shi; Jun Chen; Ke Li; Yifu Tan; Liwei Chen; Yuwei Wu; Ting Wang; Xiaoqin Liu; Ting Jiang; Dongming Peng; Zhenbao Liu
Journal:  Trends Analyt Chem       Date:  2022-07-19       Impact factor: 14.908

Review 2.  Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments.

Authors:  Niaz Mahmud; Muzahidul I Anik; M Khalid Hossain; Md Ishak Khan; Shihab Uddin; Md Ashrafuzzaman; Md Mushfiqur Rahaman
Journal:  ACS Appl Bio Mater       Date:  2022-05-18

Review 3.  Nanotechnology-based approaches in the fight against SARS-CoV-2.

Authors:  Alrayan Abass Albaz; Misbahuddin M Rafeeq; Ziaullah M Sain; Wael Abdullah Almutairi; Ali Saeed Alamri; Ahmed Hamdan Aloufi; Waleed Hassan Almalki; Mohammed Tarique
Journal:  AIMS Microbiol       Date:  2021-10-12

Review 4.  Aptamers in Virology-A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy.

Authors:  Tejabhiram Yadavalli; Ipsita Volety; Deepak Shukla
Journal:  Pharmaceutics       Date:  2021-10-09       Impact factor: 6.321

Review 5.  Aptamers-Diagnostic and Therapeutic Solution in SARS-CoV-2.

Authors:  Tomasz Wandtke; Ewelina Wędrowska; Marcin Szczur; Grzegorz Przybylski; Marek Libura; Piotr Kopiński
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

Review 6.  Recent advances of functional nucleic acid-based sensors for point-of-care detection of SARS-CoV-2.

Authors:  Wenxian Zhang; Ying He; Zhe Feng; Jingjing Zhang
Journal:  Mikrochim Acta       Date:  2022-03-02       Impact factor: 6.408

Review 7.  A review on corona virus disease 2019 (COVID-19): current progress, clinical features and bioanalytical diagnostic methods.

Authors:  Fariba Mollarasouli; Nader Zare-Shehneh; Mehrorang Ghaedi
Journal:  Mikrochim Acta       Date:  2022-02-14       Impact factor: 6.408

8.  Blocking SARS-CoV-2 Delta Variant (B.1.617.2) Spike Protein Receptor-Binding Domain Binding with the ACE2 Receptor of the Host Cell and Inhibiting Virus Infections Using Human Host Defense Peptide-Conjugated Graphene Quantum Dots.

Authors:  Avijit Pramanik; Poonam C Sharma; Shamily Patibandla; Ye Gao; Vinod Ruppa-Kasani; Jagruti Goli; Animesh Kumar; Abhirup Chatterjee; Sudarson Sekhar Sinha; John T Bates; Michael A Bierdeman; Ritesh Tandon; Paresh Chandra Ray
Journal:  ACS Omega       Date:  2022-02-22

Review 9.  Aptamer Applications in Emerging Viral Diseases.

Authors:  Arne Krüger; Ana Paula de Jesus Santos; Vanessa de Sá; Henning Ulrich; Carsten Wrenger
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-28

10.  Aptamer Sandwich Assay for the Detection of SARS-CoV-2 Spike Protein Antigen.

Authors:  Marketa Svobodova; Vasso Skouridou; Miriam Jauset-Rubio; Irene Viéitez; Alberto Fernández-Villar; Jorge Julio Cabrera Alvargonzalez; Eva Poveda; Clara Benavent Bofill; Teresa Sans; Abdulaziz Bashammakh; Abdulrahman O Alyoubi; Ciara K O'Sullivan
Journal:  ACS Omega       Date:  2021-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.